TABLE 2.
Primary | Restrictive | |
---|---|---|
Outcomea | Outcome | |
Age, y, % | ||
<15 | 44.2 | 11.1 |
≥15 | 29.0 | 5.4 |
P < .001 | P < .001 | |
Sex, % | ||
Male | 33.2 | 7.1 |
Female | 39.0 | 8.8 |
P = .01 | P = .11 | |
Race and ethnicity, % | ||
Non-Hispanic white | 36.3 | 7.5 |
Non-Hispanic African American | 37.0 | 8.5 |
Hispanic | 35.2 | 8.5 |
Other | 35.3 | 6.8 |
P = .80 | P = .94 | |
BMI, % | ||
Normal | 37.8 | 7.9 |
Overweight or obese | 34.3 | 8.2 |
P = .14 | P = .21 | |
Passed out or nearly passed out from shot or blood draw in the past 5 y, % |
||
No | 35.4 | 7.5 |
Yes | 47.8 | 15.1 |
P = .009 | P = .02 | |
Hunger or thirst at the time of enrollment, % | ||
Not at all or a little bit | 35.3 | 7.2 |
Very | 39.2 | 10.9 |
P = .13 | P = .02 | |
Tired at the time of enrollment, % | ||
Not at all or a little bit | 35.6 | 7.8 |
Very | 40.1 | 13.9 |
P = .36 | P = .07 | |
Prevaccination anxiety, % | ||
None or slight | 33.9 | 6.3 |
Mild, moderate, or severe | 40.8 | 11.5 |
P = .004 | P < .001 | |
No. of injectable vaccines,b % | ||
1 | 30.6 | 5.2 |
>1 | 43.7 | 11.8 |
P < .001 | P < .001 | |
Receipt of HPV vaccine, % | ||
No | 33.8 | 7.3 |
Yes | 38.3 | 8.5 |
P = .02 | P = .11 | |
Pain intensity after vaccination, % | ||
0–1 | 31.9 | 5.1 |
2–5 | 62.0 | 26.1 |
P < .001 | P < .001 |
The primary outcome is “a little bit” or more in response to any of the 12 items on the presyncope instrument. The restrictive outcome is “somewhat” or more in response to any of the 12 items on the presyncope instrument.
Including intramuscularly and subcutaneously administered vaccines.